To: | Enzo Life Sciences, Inc. (Laurasmithtmesq@gmail.com) |
Subject: | U.S. Trademark Application Serial No. 88605246 - AMPIXTRACT - N/A |
Sent: | October 21, 2019 03:07:39 PM |
Sent As: | ecom116@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88605246
Mark: AMPIXTRACT
|
|
Correspondence Address: |
|
Applicant: Enzo Life Sciences, Inc.
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: October 21, 2019
USPTO database searched; no conflicting marks found. The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d). 15 U.S.C. §1052(d); TMEP §704.02.
Application has been amended as shown below. As agreed to by Laura E. Smith on October 18, 2019, the examining attorney has amended the application as shown below. Please notify the examining attorney immediately of any objections. TMEP §707. Otherwise, no response is required. Id. In addition, applicant is advised that amendments to the goods and/or services are permitted only if they clarify or limit them; amendments that add to or broaden the scope of the goods and/or services are not permitted. 37 C.F.R. §2.71(a).
The identification of goods is amended to read as follows: “Nucleic acid isolation kits comprised of isolation buffers, binding buffers, elution buffers, beads, spin columns and collection tubes for use in isolating nucleic acid from various sample types including tissue, urine, blood and cells, for downstream applications.” See TMEP §§1402.01, 1402.01(e).
/SeanCrowley
Examining Attorney
Law Office 116
U.S. Patent and Trademark Office
571.272.8851
sean.crowley@uspto.gov